Hormone therapy may reduce kyphosis development — 3 takeaways


The Women's Health Initiative researchers investigated the impact of hormone therapy on hyperkyphosis development.

The study encompassed 9,700-plus women aged 65 years or older within a 15-year timeframe.


Menopause published the study.


Here are three takeaways:


1. The women who reported continuous or remote past hormone therapy developed less-pronounced kyphosis by their mid-80s compared to the nonusers.


2. Researchers concluded their findings support hormone therapy as a potential postmenopause treatment for those women who may develop fractures or posture abnormalities.


3. Further, the benefits of hormone therapy continued beyond treatment.




Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers